News
Shares of Torrent Pharmaceuticals hit a 52-week high in early trade as brokerages cheered in-line Q1FY26 results. Its net ...
21h
NDTV Profit on MSNTorrent Pharma Q1 Review: Citi Hikes Target Price — Here's WhyTorrent Pharma's India sales grew 11% year-on-year, led by out performance in the focused therapies as its chronic sales grew ...
Global brokerage Citi has maintained a 'Sell' rating with a target of ₹765 per share, according to reports. The brokerage ...
Of the 44 analysts that have coverage on IndusInd Bank, 24 of them continue to have a 'Sell' rating, 14 say 'Hold', while six ...
Lodha Developers: Motilal Oswal Retains 'Buy' Despite Below Estimate Q1 Results — Check Target Price
Though Lodha's Q1 result were below Motilal Oswal's estimate, the presales and business development momentum remains intact ...
BEL share price slips despite strong margins and order inflows; Nomura downgrades, while UBS and JP Morgan stay bullish.
On May 6, Electronic Arts reported fourth-quarter earnings of $1.58 per share, which beat the analyst consensus estimate of ...
IndusInd Bank posts steep profit drop in Q1FY26 as asset quality deteriorates; see what brokerages recommend for investors.
The BEL's consolidated net profit rose 23% to ₹969.91 crore in Q1FY26 as against ₹791 crore in the same period last year.
SBI Cards shares fell 6.1% to ₹834.75 after weak June quarter results, marking a fourth straight profit decline. Net profit ...
Analysts have revised their ratings and price targets for SBI Cards and Payment Services stock, sending a mixed-to-cautious ...
Zen Technologies' Q1 results were muted given a slowdown in order inflow momentum that persisted for a fifth quarter in a row ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results